<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Notice of Intent To Grant an Exclusive License</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Notice of Intent To Grant an Exclusive License</h1>
    <p class="timestamp">Published: 2018-04-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to Meiogen Biotechnology Corporation, 20 Assembly Square Drive, Somerville, MA 02145, an exclusive license to U.S. patent application No. 62/571,900 ("Compositions and Methods of Interferon Alpha Binding Proteins") VA Invention Disclosure number 2018-010 titled, "B18R (Normferon<SUP>TM</SUP>-alpha)." The invention provides compositions comprising ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Veterans Affairs Department</p>
    <p><strong>Document Number:</strong> 2018-07844</p>
    <p><strong>Publication Date:</strong> 2018-04-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/04/16/2018-07844/notice-of-intent-to-grant-an-exclusive-license">https://www.federalregister.gov/documents/2018/04/16/2018-07844/notice-of-intent-to-grant-an-exclusive-license</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-07844</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
